DK1019048T3 - Anvendelse af en angiotensin II-reseptorantagonist til fremstilling af lægemidler til forøgelse af overlevelsesfrekvensen af nyretransplanterede patienter - Google Patents

Anvendelse af en angiotensin II-reseptorantagonist til fremstilling af lægemidler til forøgelse af overlevelsesfrekvensen af nyretransplanterede patienter

Info

Publication number
DK1019048T3
DK1019048T3 DK98946713T DK98946713T DK1019048T3 DK 1019048 T3 DK1019048 T3 DK 1019048T3 DK 98946713 T DK98946713 T DK 98946713T DK 98946713 T DK98946713 T DK 98946713T DK 1019048 T3 DK1019048 T3 DK 1019048T3
Authority
DK
Denmark
Prior art keywords
transplant patients
preparation
increase
receptor antagonist
survival rate
Prior art date
Application number
DK98946713T
Other languages
Danish (da)
English (en)
Inventor
Giuseppe Remuzzi
Original Assignee
Merck Sharp Dohme Italia S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp Dohme Italia S P A filed Critical Merck Sharp Dohme Italia S P A
Application granted granted Critical
Publication of DK1019048T3 publication Critical patent/DK1019048T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK98946713T 1997-09-30 1998-09-30 Anvendelse af en angiotensin II-reseptorantagonist til fremstilling af lægemidler til forøgelse af overlevelsesfrekvensen af nyretransplanterede patienter DK1019048T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97RM000586A IT1295405B1 (it) 1997-09-30 1997-09-30 Uso di un antagonista recettoriale di angiotensina ii per la preparazione di farmaci per aumentare il tasso di sopravvivenza di
PCT/IT1998/000259 WO1999016437A1 (fr) 1997-09-30 1998-09-30 Utilisation d'un antagoniste du recepteur de l'angiotensine ii pour la preparation de medicaments servant a accroitre le taux de survie des patients ayant subi une transplantation renale

Publications (1)

Publication Number Publication Date
DK1019048T3 true DK1019048T3 (da) 2004-05-03

Family

ID=11405271

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98946713T DK1019048T3 (da) 1997-09-30 1998-09-30 Anvendelse af en angiotensin II-reseptorantagonist til fremstilling af lægemidler til forøgelse af overlevelsesfrekvensen af nyretransplanterede patienter

Country Status (12)

Country Link
US (1) US6576652B2 (fr)
EP (1) EP1019048B1 (fr)
JP (1) JP2001517698A (fr)
AT (1) ATE258051T1 (fr)
AU (1) AU754852B2 (fr)
CA (1) CA2303217C (fr)
DE (1) DE69821252T2 (fr)
DK (1) DK1019048T3 (fr)
ES (1) ES2213296T3 (fr)
IT (1) IT1295405B1 (fr)
PT (1) PT1019048E (fr)
WO (1) WO1999016437A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638937B2 (en) 1998-07-06 2003-10-28 Bristol-Myers Squibb Co. Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
BR0102252B1 (pt) 2001-04-10 2013-10-22 Sistema de liberação controlada para antagonista do receptor AT1 da angiotensina II, composição farmacêutica e seu uso
DE60304175T2 (de) 2002-04-29 2007-03-15 Teva Pharmaceutical Industries Ltd. Verfahren zur herstellung von losartan und losartan-kaliumsalz
WO2005097109A1 (fr) * 2004-04-01 2005-10-20 Daniel Batlle Methodes pour obtenir un niveau d'expression d'ace2 protecteur
WO2005110386A2 (fr) * 2004-04-13 2005-11-24 Wisconsin Alumni Research Foundation Methode permettant de reduire l'inflammation lors d'une greffe de rein a l'aide d'agents bloquant les recepteurs de l'angiotensine
US7531560B2 (en) * 2004-11-10 2009-05-12 Boehringer Ingelheim Pharmaceuticals, Inc. Anti-cytokine heterocyclic compounds
ES2753874T3 (es) * 2009-04-28 2020-04-14 Daiichi Sankyo Co Ltd Cristales de solvato novedosos
AU2013345894B2 (en) * 2012-11-14 2017-05-25 Teijin Limited Pyridine derivative
WO2018002673A1 (fr) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Nouvelles formulations d'antagonistes du récepteur de l'angiotensine ii
AU2019246406A1 (en) * 2018-03-29 2020-10-15 Bruno Reichart Compositions for prolonging the survival after orthopic and heteropic xenogeneic heart, kidney, lung or liver transplantations

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH528514A (de) 1969-05-22 1972-09-30 Bayer Ag Verfahren zur Herstellung von Acylimidazolen
JPS54148788A (en) 1978-05-15 1979-11-21 Takeda Chem Ind Ltd 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative and its preparation
JPS55313A (en) 1978-06-13 1980-01-05 Kissei Pharmaceut Co Ltd Imidazole derivative
DK531479A (da) 1979-01-19 1980-07-20 Pfizer Fremgangsmaade til fremstilling af imidazolderivater og salte deraf
JPS5671073A (en) 1979-11-12 1981-06-13 Takeda Chem Ind Ltd Imidazole derivative
JPS5671074A (en) 1979-11-12 1981-06-13 Takeda Chem Ind Ltd 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative
DE3106150A1 (de) 1981-02-13 1982-09-16 Schering Ag, 1000 Berlin Und 4619 Bergkamen "verfahren zur herstellung von imidazolessigsaeurederivaten"
JPS58157768A (ja) 1982-03-16 1983-09-19 Takeda Chem Ind Ltd ４−クロロ−２−フエニルイミダゾ−ル−５−酢酸誘導体
PT78388B (en) 1983-04-12 1986-09-15 Smithkline Beckman Corp Dopamine-beta-hydroxylase inhibitors
FI833794A0 (fi) 1983-10-18 1983-10-18 Farmos Oy Substituerade 2-merkapto-imidazoler
US5138069A (en) 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
US5064825A (en) * 1989-06-01 1991-11-12 Merck & Co., Inc. Angiotensin ii antagonists
EP0505098A1 (fr) * 1991-03-19 1992-09-23 Merck & Co. Inc. Dérivés d'imidazole ayant des groupes fonctionnels acides comme angiotensin II antagonistes
US5492904A (en) * 1991-05-15 1996-02-20 E. I. Du Pont De Nemours And Company Composition of angiotensin-II receptor antagonists and calcium channel blockers
US5130439A (en) 1991-11-18 1992-07-14 Lo Young S Tetrazolylphenylboronic acid intermediates for the synthesis of AII receptor antagonists
DE69233208T2 (de) 1991-11-18 2004-07-08 E.I. Du Pont De Nemours And Co., Wilmington Tetrazolylphenylborsäureintermediate zur synthese von aii rezeptor antagonisten
US5219856A (en) * 1992-04-06 1993-06-15 E. I. Du Pont De Nemours And Company Angiotensin-II receptor blocking, heterocycle substituted imidazoles
US5310929A (en) * 1992-08-06 1994-05-10 E. I. Du Pont De Nemours And Company Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists
US5395844A (en) * 1993-06-10 1995-03-07 The Du Pont Merck Pharmaceutical Company Imidazole 5-position substituted angiotensin II antagonists
BR9611007A (pt) * 1995-10-06 1999-07-13 Novartis Ag Antagonistas do receptor at1 para prevenir e tratar a deficiência renal pós-isquêmica e para a proteção de rins isquêmicos
CA2238975A1 (fr) * 1995-12-12 1997-06-19 Merck & Co., Inc. Nouvelle utilisation du losartan

Also Published As

Publication number Publication date
US20020115702A1 (en) 2002-08-22
PT1019048E (pt) 2004-05-31
AU754852B2 (en) 2002-11-28
DE69821252T2 (de) 2004-11-18
CA2303217A1 (fr) 1999-04-08
EP1019048A1 (fr) 2000-07-19
DE69821252D1 (de) 2004-02-26
JP2001517698A (ja) 2001-10-09
ITRM970586A1 (it) 1999-03-30
ATE258051T1 (de) 2004-02-15
WO1999016437A1 (fr) 1999-04-08
IT1295405B1 (it) 1999-05-12
CA2303217C (fr) 2005-08-09
EP1019048B1 (fr) 2004-01-21
AU9366698A (en) 1999-04-23
ES2213296T3 (es) 2004-08-16
US6576652B2 (en) 2003-06-10

Similar Documents

Publication Publication Date Title
EP0324377B1 (fr) Imidazoles à activité bloquante de récepteur de l'angiotensine II et leurs combinaisons avec des agents diurétiques et NSaids
ATE146076T1 (de) Behandlung des chronischen nierenversagens mit imidazol-angiotensin-ii-rezeptorantagonisten
KR910007918A (ko) 치환된5-[(테트라졸릴)알케닐]이미다졸
DK1019048T3 (da) Anvendelse af en angiotensin II-reseptorantagonist til fremstilling af lægemidler til forøgelse af overlevelsesfrekvensen af nyretransplanterede patienter
BR0215202A (pt) Compostos antagonistas seletivos a2b de pirimidina, sua sìntese e uso
CA2643005A1 (fr) Derives d'acide imidazol-5-carboxylique, leurs procedes de preparation et leur utilisation
EP1327631A3 (fr) Composés hétérocycliques condensés, leur préparation et utilisation comme angiotensine II antagonistes
KR960704884A (ko) 항종양제 또는 항바이러스제로서의 디스타마이신 A 동족체 (Distamycin A analogues as antitumour or antiviral agents)
RU98118906A (ru) Амидные производные или их соли
DE60130256D1 (de) Naphthalinderivate, die sich an den ep4?rezeptor binden
TW200630352A (en) Chemical compounds
NO914236D0 (no) Fremstilling og anvendelse av tienoimidazolderivater
MXPA05008142A (es) Medicamento para la profilaxis y el tratamiento de arteriosclerosis e hipertension.
RS20080510A (en) Benzimidazole derivative and use as angiotensin ii antagonist
FI942282A0 (fi) Tetratsolyylifenyyliboorihappovälituotteita AII-reseptoriantagonistien synteesiä varten
US20230372372A1 (en) Combination therapies using caspase-1 dependent anticancer agents and pge2 antagonists
CA2420055A1 (fr) Agent de reduction du fibrinogene
JPH06503337A (ja) 再狭窄の予防におけるアンジオテンシン２受容体拮抗剤の使用
DK0752854T3 (da) Pyrimidin- eller triazincarboxylsyrederivater til anvendelse som lægemiddel
JPH06503322A (ja) 梗塞形成の処置におけるアンジオテンシン２拮抗剤の使用
CY1110950T1 (el) Ενωσεις ιμιδαζολιδινονυλ αμινοπυριμιδινης για τη θεραπευτικη αντιμετωπιση του καρκινου
RU2001105092A (ru) Имидазольные соединения и их применение в качестве ингибиторов аденозиндезаминазы
US20020058686A1 (en) Medicament
EP1884240A4 (fr) Produit pharmaceutique pour la prévention ou le traitement d'une maladie métabolique osseuse
CA2421826A1 (fr) Imidazoles substituees utilisees comme agonistes ou antagonistes duales d'histamine h1 et h2